References
Lipinski MM, Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene 1999; 18: 7873–7882.
Weinberg RA. The retinoblastoma protein and cell cycle control. Cell 1995; 81: 323–330.
Zheng L, Lee WH. The retinoblastoma gene: A prototypic and multifunctional tumor suppressor. Exp Cell Res 2001; 264: 2–18.
Harbour JW, Dean DC. Rb function in cell-cycle regulation and apoptosis. Nat Cell Biol 2000; 2: E65–E67.
Macleod K. pRb and E2f-1 in mouse development and tumorigenesis. Curr Opin Genet Dev 1999; 9: 31–39.
Fogal V, Hsieh JK, Royer C, Zhong S, Lu X. Cell cycle-dependent nuclear retention of p53 by E2F1 requires phosphorylation of p53 at Ser315. Embo J 2005; 24: 2768–2782.
Hsieh JK, Yap D, O'Connor DJ, et al. Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol 2002; 22: 78–93.
Wu XW, Levine AJ. p53 and E2F-1 cooperate to mediate apoptosis. Proc Natl Acad Sci USA 1994; 91: 3602–3606.
Prives C. Signaling to p53: Breaking the MDM2-p53 circuit. Cell 1998; 95: 5–8.
Hershko T, Chaussepied M, Oren M, Ginsberg D. Novel link between E2F and p53: Proapoptotic cofactors of p53 are transcriptionally upregulated by E2F. Cell Death Differ 2005; 12: 377–383.
Decary S, Decesse JT, Ogryzko V, et al. The retinoblastoma protein binds the promoter of the survival gene bcl-2 and regulates its transcription in epithelial cells through transcription factor AP-2. Mol Cell Biol 2002; 22: 7877–7888.
Lipinski MM, Macleod KF, Williams BO, et al. Cell-autonomous and non-cell-autonomous functions of the Rb tumor suppressor in developing central nervous system. Embo J 2001; 20: 3402–3413.
Haupt Y, Rowan S, Oren M. p53-mediated apoptosis in HeLa cells can be overcome by excess pRb. Oncogene 1995; 10: 1562–1571.
Shinohara H, Zhou J, Yoshikawa K, et al. Retinoblastoma protein-initiated cellular growth arrest overcomes the ability of cotransfected wild-type p53 to induce apoptosis. Br J Cancer 2000; 83: 1039–1046.
Osifchin NE, Jiang D, Ohtani-Fujita N, et al. Identification of a p53 binding site in the human retinoblastoma susceptibility gene promoter. J Biol Chem 1994; 269: 6383–6389.
Porrello A, Cerone MA, Coen S, et al. p53 regulates myogenesis by triggering the differentiation activity of pRb. J Cell Biol 2000; 151: 1295–1304.
Sionov RV, Haupt Y. The cellular response to p53: The decision between life and death. Oncogene 1999; 18: 6145–6157.
Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994; 371: 72–74.
Symonds H, Krall L, Remington L, et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994; 78: 703–711.
Zhao X, Day ML. RB activation and repression of C-MYC transcription precede apoptosis of human prostate epithelial cells. Urology 2001; 57: 860–865.
Bowen C, Birrer M, Gelmann EP. Retinoblastoma protein-mediated apoptosis after gamma-irradiation. J Biol Chem 2002; 277: 44969–44979.
Bowen C, Spiegel S, Gelmann EP. Radiation-induced apoptosis mediated by retinoblastoma protein. Cancer Res 1998; 58: 3275–3281.
Day ML, Foster RG, Day KC, et al. Cell anchorage regulates apoptosis through the retinoblastoma tumor suppressor/E2F pathway. J Biol Chem 1997; 272: 8125–8128.
Knudsen KE, Weber E, Arden KC, et al. The retinoblastoma tumor suppressor inhibits cellular proliferation through two distinct mechanisms: Inhibition of cell cycle progression and induction of cell death. Oncogene 1999; 18: 5239–5245.
Hsieh JK, Chan FS, O'Connor DJ, et al. RB regulates the stability and the apoptotic function of p53 via MDM2. Mol Cell 1999; 3: 181–193.
Bremner R, Du DC, Connolly-Wilson MJ, et al. Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma. Am J Hum Genet 1997; 61: 556–570.
Lemaire C, Godefroy N, Costina-Parvu I, et al. Caspase-9 can antagonize p53-induced apoptosis by generating a p76Rb truncated form of Rb. Oncogene 2005; 24: 3297–3308.
Chen WD, Otterson GA, Lipkowitz S, et al. Apoptosis is associated with cleavage of a 5 kDa fragment from RB which mimics dephosphorylation and modulates E2F binding. Oncogene 1997; 14: 1243–1248.
Boutillier AL, Trinh E, Loeffler JP. Caspase-dependent cleavage of the retinoblastoma protein is an early step in neuronal apoptosis. Oncogene 2000; 19: 2171–2178.
Janicke RU, Walker PA, Lin XY, Porter AG. Specific cleavage of the retinoblastoma protein by an ICE-like protease in apoptosis. Embo J 1996; 15: 6969–6978.
Fattman CL, Delach SM, Dou QP, Johnson DE. Sequential two-step cleavage of the retinoblastoma protein by caspase-3/-7 during etoposide-induced apoptosis. Oncogene 2001; 20: 2918–2926.
Chau BN, Borges HL, Chen TT, et al. Signal-dependent protection from apoptosis in mice expressing caspase-resistant Rb. Nat Cell Biol 2002; 4: 757–765.
Gottlieb E, Oren M. p53 facilitates pRb cleavage in IL-3-deprived cells: Novel pro-apoptotic activity of p53. Embo J 1998; 17: 3587–3596.
Lozano G, Zambetti GP. Gankyrin: An intriguing name for a novel regulator of p53 and RB. Cancer Cell 2005; 8: 3–4.
Uchida C, Miwa S, Kitagawa K, et al. Enhanced Mdm2 activity inhibits pRB function via ubiquitin-dependent degradation. Embo J 2005; 24: 160–169.
Stiewe T, Stanelle J, Theseling CC, et al. Inactivation of retinoblastoma (RB) tumor suppressor by oncogenic isoforms of the p53 family member p73. J Biol Chem 2003; 278: 14230–14236.
Liu H, Dibling B, Spike B, Dirlam A, Macleod K. New roles for the RB tumor suppressor protein. Curr Opin Genet Dev 2004; 14: 55–64.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Godefroy, N., Lemaire, C., Mignotte, B. et al. p53 and Retinoblastoma protein (pRb): A complex network of interactions. Apoptosis 11, 659–661 (2006). https://doi.org/10.1007/s10495-006-5543-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10495-006-5543-y